Risking FTC Scrutiny, Direct Seller Ignores Industry Self-Regulation Group On COVID-19 Claims
Executive Summary
Direct seller Flavon USA is referred to FTC after it failed to respond to repeated outreach by Direct Selling Self-Regulatory Council over claims its supplements treat coronavirus. The watchdog asked for substantiation of claims suggesting products also could tumors and diabetes.
You may also be interested in...
UK Researchers Seek Commercial Partner For Nasal Spray Shown To ‘Prevent’ COVID-19
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.
Immunity, Weight Loss Supplement Marketers Risk FTC Scrutiny By Ignoring Industry Self-Regulation
NAD forwards to regulatory agency its concerns about claims by Hypernatural and Letitox Nutrition after they didn’t participate in the industry self-regulation forum. Both firms’ claims were challenged by the Council for Responsible Nutrition as part of a program with NAD it previously supported.
Direct Sales Industry Guidance Responds To ‘Increase In Questionable Earnings Claims’
Direct Selling Self-Regulatory Council and Direct Selling Association guidance aims to curb multi-level marketers’ misleading earnings claims, a practice increasing among health and wellness direct sellers during the COVID-19 pandemic.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: